The great expansion of mobile technology across the globe has facilitated the use of smartphone applications to improve health systems and engage people in public health processes. This approach has been specially applied in low and middle income countries where capitalizing on the ubiquity of mobile technology infrastructure can help to overcome widespread health system barriers such as health personnel shortages, cost of health service, and transportation. Mobile health (mHealth) is a growing field with several applications in maternal and child health programmes dedicated to health monitoring,
Johnson & Johnson plans to test its coronavirus vaccine in infants and even in newborns, as well as in pregnant women and in people who have compromised immune systems.
The bold plan for expanded clinical trials met with the approval of Dr. Ofer Levy, director of the Precision Vaccines Program at Harvard’s Boston Children’s Hospital and a member of the Food and Drug Administration advisory committee that reviewed the company’s vaccine data.
Authors: A E Ades, Elizabeth B Brickley, Neal Alexander, David Brown, Thomas Jaenisch, Demócrito de Barros Miranda-Filho, Moritz Pohl, Kerstin D Rosenberger, Antoni Soriano-Arandes , Claire Thorne et al.
Published in: BMJ Journals
Introduction Zika virus (ZIKV) infection in pregnancy has been associated with microcephaly and severe neurological damage to the fetus.
This online educational program will be presented by Dr Lynne Mofenson, of the Elizabeth Glaser Pediatric AIDS Foundation, on October 13th 2020.
Dr Mofenson’s talk will focus on the effects of COVID-19 in pregnant women and possible mother to child transmission during breastfeeding.
Join us to hear important insights into the clinical characteristics and possible risks associated with COVID-19 during the pregnancy and postnatal period.